SEARCH

APPLICATIONS​

Product Type

Quantifiables

Compatibility

Relevance

Trans – MSC

Apoptosis, Necrosis, Vacuolization, inflammatory Interleukins, LD50, Delayed-type hypersensitivity (DTH), mitogen- or antigen-stimulated lymphocyte proliferative responses, macrophage function, and primary antibody response to T-cell dependent antigen, alteration in proto-oncogenes of tumor suppressor gene mutation, gene mutations, pluripotency, multipotency, bipotency, unipotency, tumor inducing property, stem cell DNA damage, stem cell mutation, inflammatory cascade, tumor formation, drug distribution ratio

Acute mammalian toxicity
Chronic toxicity
Cell penetration tests
Receptor binding tests
Eye/Skin corrosion tests
Cytotoxicity/Cell function based invitro tests
Genotoxicity tests
Developmental toxicity tests
Potency tests

Contract Research Organizations
Toxicity testing labs
Pharma
Biotech R&D

Trans – HSC

Hematotoxicity specific Colony Forming Units (of hematopoietic precursor cells of various types), Spreading properties of platelets, Blood cell metabolic or functional changes and their dose response relationships, Development of micronuclei, Of any chromosomal aberrations

Hematotoxicity tests
Pyrogenicity tests

Contract Research Organizations
Toxicity testing labs
Pharma
Biotech R&D

Trans-TR-B

Breast cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations
Pharma in Oncology R&D

Trans-TR-H&N

Head & Neck cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations
Pharma in Oncology R&D

Trans-TR-C

Colon cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations
Pharma in Oncology R&D

Trans-TR-O

Ovarian cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations
Pharma in Oncology R&D

Transchymal™-UC

To build 3D organs, human tissue (trachea, heart, liver, bone) engineering

N/A

3D Bioprinting companies
Biotechs in Tissue engineering
Exosomes research companies

Transchymal™-DP

To build 3D neural network, 3D periodontum, 3D tooth, cornea

N/A

3D Bioprinting companies
Biotechs in Tissue engineering
Exosomes research companies

Transchymal™ -AD

To build 3D breast

N/A

3D Bioprinting companies
Biotechs in Tissue engineering
Exosomes research companies

Trans-CT

Phenotype , Genotype test end points on Human Skin tissue model

Reliability Test, Residual Antibacterial Test,Invitro Skin Substrate Assay

Cosmetic Testing Labs

Trans-TT

Invitro Phenotype, Genotype & Proteomics assay end points in Oncology Drug discovery

Spheroid Assay, Invitro Toxicity Tests, Invitro Preclinical Exploratory Research in Oncology

Drug Discovery in Oncology

Number of Views : 98 total views,  1 views today

Back to Top